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Disease 
PreventionI N T R O D U C T I O N
It Takes More Than 
an Apple a Day
AS MODELS FOR PREVENTION RESEARCH, INFECTIOUS DISEASES HAVE SET A HIGH 
standard. Thanks to the development and widespread distribution of vaccines and 
anti microbial drugs, we now live in a world free of smallpox, nearly free of polio, 
and with declining rates of malaria and AIDS. These victories (some still partial) 
have resulted in people living longer and acute infectious diseases being super-
seded in many countries as a public health priority by long-term noncommuni-
cable diseases. Heart disease, metabolic disease, cancer, and respiratory disease 
together account for 60% of all deaths worldwide and 80% of deaths in low- and 
middle-income countries. Global projections for dementia are particularly alarm-
ing: By the year 2050, the disorder may affect more than 100 million people.
Logic dictates that preventing these diseases is a better approach than treat-
ing people after they have become ill. In many cases, the knowledge and tools 
needed for prevention appear to be in place. A number of these killer diseases 
share risk factors that can be modiﬁ ed by lifestyle changes—for example, by 
eliminating tobacco use, eating less processed food, and increasing physical 
activity. For certain cancers, screening tests are available that allow detection of 
the disease at an early stage. So why is prevention of these diseases so difﬁ cult 
when it seems like such a good idea on paper? 
This special section of Science highlights many of the challenges facing 
researchers in noncommunicable disease prevention, a ﬁ eld characterized by 
impassioned debates on issues as fundamental as whether the beneﬁ ts of can-
cer screening outweigh the risks, and which forms of prevention are the most 
cost-effective. The need for carefully designed clinical trials is a common theme 
in discussions of potential chemopreventive agents—among them aspirin, 
vitamin D, vaccines against chronic diseases, and β-amyloid–lowering drugs. 
The preventive strategies most likely to succeed on a population-wide scale are 
described, as are the best ways to integrate these efforts with infectious disease 
prevention, and the far-reaching effects (some adverse) that disease prevention 
efforts could have on a country’s economy. And even as medical researchers 
seek new prevention drugs and strategies, we are reminded that lifelong health 
requires proper nutrition, especially during the ﬁ rst 1000 days of life, and that 
effective prevention will require an understanding of why people engage in 
health-harming behaviors.
One year ago this month, the United Nations convened a conference focused 
on the global reach of noncommunicable diseases, and it has since set a goal: to 
reduce the probability of premature mortality from these diseases by 25% by the 
year 2025. Although the speciﬁ cs are still a work in progress, preventive strat-
egies will probably play an important role. As if prevention researchers didn’t 
already face enough challenges, they now ﬁ nd themselves working on a deadline. 
– CAROLINE ASH, PAULA KIBERSTIS, ELIOT MARSHALL, JOHN TRAVIS
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